Accelerated vaccine development against emerging infectious diseases

 Abstract

Emerging and re-emerging infectious diseases represent a major challenge to vaccine development since it involves two seemingly contradictory requirements. Rapid and flexible vaccine generation while using technologies and processes that can facilitate accelerated regulatory review. Development in the “-omics” in combination with advances in vaccinology offer novel opportunities to meet these requirements. Here we describe how a consortium of five different organizations from academia and industry is addressing these challenges. This novel approach has the potential to become the new standard in vaccine development allowing timely deployment to avert potential pandemics.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
1010 - 1012
doi
10.4161/hv.20805
Type
Commentary
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Accelerated vaccine development against emerging infectious diseases